ISPE

NOVEMBER 10, 2022

So called “personalized” treatments with cell therapy include taking cells from a patient, performing the genetic manipulation, and then putting them back into the same patient (autologous); another approach involves supplying modified cells to a pool of patients with a related makeup and disorder (allogeneic). Shin Kawamata, MD, PhD.

Documentation 98

Documentation Compounding Hospitals Immunization 98

PharmaShots

FEBRUARY 27, 2023

Mr. Mekala Rao The topic discussed by Mr. Mekala was Metaverse: Healthcare and its role in this Game changing Technology. The speakers shared their views on the topic: Dr. Jagadeesh Babu Rangisetty- “COVID has taught us so many things and the pharmaceutical company has gone through a lot of challenges and at the same time opportunities.

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40

ISPE

MARCH 6, 2023

2 Many have a narrower, focused view of the topic—simply envisioning the reduction of environmental impacts through use of “greener” technology.

Communication 52

Communication Patient Care 52

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 7, 2023

Research and development, manufacturing, commercial (sales and marketing) activities, and their extended supply chains including logistics are all within this scope. Alternative sources of supply may be sought if suppliers cannot meet their customer expectations. 1 United Nations. 3 Science Based Targets Initiative.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

Pharmaceutical Technology

MARCH 22, 2023

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JUNE 8, 2023

AstraZeneca has announced its supply chain will be carbon negative by 2030. GlobalData’s social media sentiment database reveals that, even over the past year, the trend towards discussion of environmental topics among pharmaceutical influencers has ramped up. Supply chains are increasingly in the spotlight.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 52